Pharmaceuticals, Biotechnology and Life Sciences
Published in the journal Vaccine, data show vaccines targeting theH10N8 and H7N9 influenza viruses to be highly immunogenic andwell-tolerated in healthy adults
The global influenza vaccines market size is expected to surpass USD 6billion by 2025.
Blue Water Vaccines, a privately held company, will complete its fund-raising of $15 million to support the flu vaccine program, after agreeing with the University of Oxford, without disclosing terms of the agreement, providing Blue Water Vaccines the option to exclusively license a novel and potentially revolutionary universal influenza vaccine.
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling…
Well-matched influenza vaccine prevents P&I hospitalizations and mortality in NH residents.